Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
暂无分享,去创建一个
[1] G. Demetri,et al. Small molecule tyrosine kinase inhibitor and depression. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Seth Wolpin,et al. Depression screening using the Patient Health Questionnaire‐9 administered on a touch screen computer , 2009, Psycho-oncology.
[3] N. Weiss,et al. Incidence of suicide in persons with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H. Mogun,et al. Cancer and the risk of suicide in older Americans. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Fallon,et al. Better off dead: suicidal thoughts in cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Bezjak,et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Kris,et al. Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Spitzer,et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.